23 May 2013
Keywords: strong, results, anadys, drug-resistant, hep, drug, pharmaceuticals
Article | 25 April 2005
Anadys Pharmaceuticals, a US drugmaker focused on anti-infectives, has reported positive data from an ongoing Phase II trial of ANA380
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 April 2005
22 May 2013
© 2013 thepharmaletter.com